Biotech - the mind boggles. The royalty would be lower as a % but total revenue much higher.
Single application maybe 4% if lucky $250m sales so $10m like you say but multiple components across multiple assays? I reckon POC1 would be happy to get it under 2% but sales revenue could grow to billions. $1b = $15-20m , $3b = $45m etc big numbers for us but small marginal cost of sales for them.
impressed to hear Philips are planning launch in 2015. I assumed 2016 to be conservative but if MnG is used we will find out about it in the next few months to achieve that timeline.
query, page-62
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $46.90M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $23.42K | 1.233M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1142321 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 339684 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| ADO (ASX) Chart |